Odonate Therapeutics Accounts Payable

Odonate Therapeutics (ODT) currently reports a accounts payable of $12M as of September 2021. That compares with $14M in the prior-year period — down 16.8% year over year. Use the charts on this page to explore Odonate Therapeutics's accounts payable history and peer comparisons.

Odonate Therapeutics's accounts payable decreased from $14M to $12M — a 16.8% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Odonate Therapeutics reported $12M in accounts payable as of September 2021. That compares with $14M in the prior-year period — down 16.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $12M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Odonate Therapeutics, and consider following ODT for alerts when major investors trade the stock.

Odonate Therapeutics is classified in the Healthcare sector. On accounts payable, it currently shows $12M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ODT with unrelated industries.